(82)Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis

BACKGROUND: Accurate identification and discrimination of post treatment changes from recurrent disease remains a challenge for patients with intracranial malignancies despite advances in molecular and magnetic resonance imaging. We have explored the ability of readily available Rubidium-82 chloride...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Q J Nucl Med Mol Imaging
Asıl Yazarlar: PARENT, Ephraim E., SETHI, Ila, NYE, Jonathon, HOLDER, Chad, OLSON, Jeffrey J., SWITCHENKO, Jeffrey, TADE, Funmilayo, AKIN-AKINTAYO, Oladunni O., ABIODUN-OJO, Olayinka A., AKINTAYO, Akinyemi, SCHUSTER, David M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2022
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958885/
https://ncbi.nlm.nih.gov/pubmed/31820882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23736/S1824-4785.19.03173-X
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller